Implications of lower- and upper-limb training procedures in patients with chronic airway obstruction
- PMID: 1576850
- DOI: 10.1378/chest.101.5_supplement.279s
Implications of lower- and upper-limb training procedures in patients with chronic airway obstruction
Abstract
In assessing the effectiveness of lower-limb and upper-limb nonspecific physical training, we have considered 3 objectives in this study: (1) determination of clinical and functional actual state in patients with chronic airway obstruction (CAO), before and after training; (2) determination of the tests, level of work, and duration of the session training as well as how to increase the training load throughout the training program; and (3) the "particular" upper-limb exercise training in patients with CAO. Many personal factors such as psychologic (personality, degree of patient motivation), alcohol and smoking habits, physical activity, malnutrition, as well as routine tests, at rest and maximal exercise, including the control of metabolic acidosis (lactate) and arterial blood gases (or at least of SaO2), should be considered. Exercise training has the potential to improve exercise tolerance in those who develop metabolic acidosis. The pattern of lactates during exercise represents a good criterion on the selection of patient's training. Two ergospirometric strategies, at high intensity exercise, established from the anaerobic threshold (AT) are described: (a) the above AT 45 min constant exercise (high work rate), at 60% of the difference between AT and maximum VO2 or 80% of the maximal tolerated power (MTP), and (b) the "45 min square-wave endurance exercise test" (SWEET), simulating an interval training session, established from the MTP and the AT. To the SWEET's base (% MTP from AT or aerobic training), a peak of 60 s at MTP (anaerobic training) is added every 5 min. While those 2 protocols, after 6 to 8 weeks of training, lactate and ventilation were lower for identical work rate. In addition, endurance (time in "a" and total physical work in "b") increased up to 60%. Further, maximal exercise ventilation and maximum VO2 increased after SWEET training. Roughly every 7 training sessions, a 10% to 15% reduction in heart rate (HR), during the training program, allows the patient to increase the work rate of the sessions. Evaluation of training the upper limb in patients with CAO requires measurements of MTP and maximum VO2. With the upper limb (wheelchair ergometer), Wmax, maximum VO2, and HR represent 30%, 65%, and 95%, respectively, of the lower limb (ergometer). Further, some expiratory and inspiratory accessory muscles show electromyographic fatigue at the MTP upper-limb level. This may contribute to the rationale for training respiratory muscles.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Ventilatory and metabolic changes as a result of exercise training in COPD patients.Chest. 1992 May;101(5 Suppl):274S-278S. doi: 10.1378/chest.101.5_supplement.274s. Chest. 1992. PMID: 1576849 Clinical Trial.
-
Exercise training in patients with chronic airways obstruction.Eur Respir J Suppl. 1989 Jul;7:611s-617s. Eur Respir J Suppl. 1989. PMID: 2679609 Review.
-
Square-wave endurance exercise test (SWEET) for training and assessment in trained and untrained subjects. I. Description and cardiorespiratory responses.Eur J Appl Physiol Occup Physiol. 1982;49(3):359-68. doi: 10.1007/BF00441297. Eur J Appl Physiol Occup Physiol. 1982. PMID: 6814906
-
Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease.Am Rev Respir Dis. 1991 Jan;143(1):9-18. doi: 10.1164/ajrccm/143.1.9. Am Rev Respir Dis. 1991. PMID: 1986689
-
The science of cycling: physiology and training - part 1.Sports Med. 2005;35(4):285-312. doi: 10.2165/00007256-200535040-00002. Sports Med. 2005. PMID: 15831059 Review.
Cited by
-
A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study.BMC Cancer. 2017 Jun 19;17(1):425. doi: 10.1186/s12885-017-3420-4. BMC Cancer. 2017. PMID: 28629338 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources